EternoGen Aesthetics is led by a group of proven industry veterans with decades of collective leadership experience in medical aesthetics. They have been responsible for the development, launch and exits of a number of the industry leading brands including RESTYLANE. EVOLENCE, RADIESSE, JUVEDERM ULTRA and BOTOX. The company founders are an award-winning group of academic researchers from University of Missouri led by Professor Sheila Grant, a world authority in bioengineering.
For a more detailed profile of each of the management team please click the image to view.
Luis R. Jimenez - President and Chief Operations Officer
His experience includes the production validation a molecular-based prostate cancer diagnostic assay with J&J. He later went on to work with Bio-tech Pharmacal, a nutraceutical manufacturing company where he designed and implemented a GMP manufacturing quality system. His experience includes operations, quality control in cGMP manufacturing, regulatory affairs for manufacturing, design engineering, technology transfer and project management. Mr. Jimenez’s background includes Chemical Engineering, Cum Laude and a Masters of Business Administration with Academic Excellence.
Dale DeVore, PhD - Chief Scientific Officer
He is a leading commercialisation scientific expert in collagen dermal filler products. He has demonstrated his ability to adapt innovative technical challenges and master subject matter. Dale's experience in dermal fillers includes founding Autologen, the 2nd dermal filler approved by the FDA. He was Vice President of R&D for BioForm Medical commercialising Radiesse® and serving in FDA panel meetings. His experience also includes consulting for Sculptra® and for CollPlant, LLD. Dale brings over 35 years in clinical development and R&D. He has authored over 75 patents in dermal filler related innovations including EternoGen’s RPC technology. He has strong expertise and experience of modifying formulations, troubleshooting issues and solving complex biochemical issues.
Charles Weatherstone - Chief Commercial Officer
He is a specialist in medical aesthetic marketing, having been responsible for the development, launch and management of a number of market leading brands including JUVEDERM® ULTRA, BOTOX®, PDS® PLATES and RESTYLANE®. Charles has almost 20 years experience in blue chip and start-up health care marketing covering both medical device and pharmaceutical sectors. Charles combines solid strategic planning, broad industry connections and creative execution to create the perfect marketing storm. He received a BSc Hons in 1991 from Southampton University, UK.
Mark Smutka has over 30 years of experience in quality assurance, regulatory affairs, and clinical affairs in the medical device industry. He has held management positions at Relievant Medsystems, AccessClosure (purchased by Cardinal Health), Flowmedica, Atrionix (purchased by Johnson and Johnson), Arthrocare, and AVE (purchased by Medtronic). Mark’s quality assurance experience includes the development, implementation and maintenance of quality systems that are compliant with FDA regulations (21 CFR 820), ISO 13485, and the Medical Device Directive (93/42/EEC as amended). His experience includes the development and implementation of regulatory and clinical strategies to bring products to market as efficiently as possible in the United States, European Union, and Australia. His clinical experience includes clinical study design, study management, statistical analysis, and report writing. His regulatory experience includes several FDA submissions, including 510(k), Investigational Device Exemption (IDE), and Premarket Approval (PMA) applications as well as Design Dossiers and Technical Files for CE Marking and other international regulatory submissions. Mark has a Bachelor of Elected Studies degree from the University of Minnesota with a major field of psychology as well as significant work in the graduate Biometry program at the School of Public Health, University of Minnesota.
Rebecca Rone, MSE - Director of Clinical and Regulatory Affairs
She received her Masters of Science Degree in Bioengineering from the University of California-San Diego with a research focus in cartilage tissue engineering. While in graduate school, Ms. Rone gained experience at BREG as a design engineer for orthopaedic, reconstructive, and postoperative medical devices. She is a co-inventor of the EternoGen’s technology. She was also Associate Director and later Director of the Coulter Translational Partnership at the University of Missouri directing over $1M in R&D grants to commercialising cutting edge research projects.